Form 8-K CONCERT PHARMACEUTICALS, For: Nov 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Concert Pharma (CNCE) Tops Q3 EPS by 6c
November 12, 2014 8:20 AM ESTConcert Pharma (NASDAQ: CNCE) reported Q3 EPS of ($0.43), $0.06 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $4.4 million versus the consensus estimate of $1.67 million.
For earnings history and earnings-related data on Concert Pharma (CNCE) click here.
... More